Search Results

319 Results for "receptos".

Sort By

Drug Development

Bird Rock Bio Completes Clinical Trial of Nimacimab in Patients with Fatty Liver Disease

Nimacimab, also known as RYI-018 or JNJ-2463, is a negative-allosteric modulating antibody targeting the cannabinoid 1 recepto

September 13, 2018
·
3 min read
Business

TP Therapeutics Appoints Sheila K. Gujrathi, MD to Board of Directors and as a Strategic Advisor

Dr. Gujrathi most recently served as Chief Medical Officer of Receptos.

December 4, 2017
·
4 min read
Business

Two Former Receptos Execs Launch New San Diego Biotech Startup With $100M

It is not clear what the new company’s focus is just yet.

January 4, 2018
·
2 min read
·
Mark Terry
Business

Endeavor BioMedicines Appoints Paul Frohna, M.D., Ph.D., as Chief Medical Officer

Endeavor BioMedicines, a clinical-stage company developing therapies for of fibrotic disease and oncology, announced the appointment of Paul Frohna, M.D., Ph.D., as its Chief Medical Officer.

November 2, 2023
·
3 min read
Deals

Celgene Commences Tender Offer For Receptos

July 28, 2015
·
5 min read
Business

Vital Therapies Appoints Former Receptos President And CEO Faheem Hasnain As Chairman Of The Board Of Directors

September 6, 2017
·
4 min read
Business

Bioniz Therapeutics Appoints Graham Cooper to its Board of Directors

Most recently, Mr. Cooper was the CFO of Receptos from 2013 until its sale in 2015 to Celgene for $7.8B.

December 6, 2017
·
2 min read
Drug Development

Celgene Admits It Screwed Up on Multiple Sclerosis Drug Application … Sort Of

This year the FDA issued a Refusal to File letter regarding its New Drug Application (NDA) for its multiple sclerosis drug ozanimod. The finger is pointed at its California subsidiary, Receptos for the failure.

June 13, 2018
·
2 min read
·
Mark Terry
Biotech Beach

Receptos To Present At UBS Global Healthcare Conference

May 14, 2015
·
1 min read
Deals

Celgene Receives Antitrust Clearance For Receptos Acquisition

August 11, 2015
·
1 min read